Insights
Stelis Biopharma receives EU-GMP certification for two of its manufacturing facilities
Stelis Biopharma, the biologics arm of Strides Pharma Science announced that
I Picked A Heck Of A Time
A new CEO’s observations on managing a fast-growing, fully integrated biophar
Stelis starts next phase of investment into its biologics manufacturing facility
This phase sees the CDMO start work on installing two 2,000-L single-use bior
Unit 1 – Bangalore, India
State-of-the-art process and analytical development facilities for small-scal
Unit 2 – Bangalore, India
Integrated state-of-the-art manufacturing facility leverages microbial and ma
Unit 3 – Bangalore, India
A multipurpose facility with an ability to cater to multiple vaccine types in
Meeting Demand for Biologics & Specialty Drugs
A company that provides insurance and investment-related products and service
Overcoming Biologic Drug Formulation Hurdles
A company that provides insurance and investment-related products and service
Stelis concludes US$ 195m Series B and Series C fund raise
Stelis Biopharma (Stelis) today announced that it has successfully concluded